Pulse Biosciences Quarterly Investor ConferenceĀ Call

Go back to Pulse Biosciences Quarterly Investor ConferenceĀ Call

Pulse Biosciences, Inc. (PLSE) Reports Q2 Loss of $0.54

July 31, 2018 4:39 PM EDT

Pulse Biosciences, Inc. (NASDAQ: PLSE) reported Q2 EPS of ($0.54).

Our progress in developing clinical applications for Nano-Pulse Stimulation continues to accelerate through 2018 as we move additional projects into the clinic and further build the portfolio of scientific evidence of our mechanism of action, stated... More